SHENZHEN, China, Dec. 27, 2010 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 22, 2010.
At the meeting, Mindray shareholders approved the re-election of incumbent directors Ms. Joyce I-Yin Hsu and Mr. Wu Qiyao, each to serve a three-year term.
In addition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers as the company's independent registered public accounting firm for the fiscal year ending December 31, 2010.
We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://www.mindray.com.
SOURCE Mindray Medical International Limited